Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
May 15, 2017	8-K	Report of unscheduled material events or corporate event	0001193125-17-170662.pdf 0001193125-17-170662.rtf 0001193125-17-170662.xls View HTML
May 9, 2017	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-17-009841.pdf 0001564590-17-009841.rtf 0001564590-17-009841.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
May 1, 2017	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-17-151781.pdf 0001193125-17-151781.rtf 0001193125-17-151781.xls View HTML
May 1, 2017	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-17-151808.pdf 0001193125-17-151808.rtf 0001193125-17-151808.xls View HTML
April 25, 2017	8-K	Report of unscheduled material events or corporate event	0001193125-17-136717.pdf 0001193125-17-136717.rtf 0001193125-17-136717.xls View HTML
April 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-001430.pdf 0001562180-17-001430.rtf 0001562180-17-001430.xls View HTML
April 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-001429.pdf 0001562180-17-001429.rtf 0001562180-17-001429.xls View HTML
April 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-001431.pdf 0001562180-17-001431.rtf 0001562180-17-001431.xls View HTML
March 31, 2017	CT ORDER	CT ORDER	9999999997-17-005213.pdf View HTML
March 6, 2017	SC 13G/A	An amendment to the SC 13G filing	0000790502-17-000002.pdf 0000790502-17-000002.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax